ZimVie announced it has expanded its cooperation agreement with Brainlab. ZimVie and Brainlab have started a joint project to achieve compatibility between ZimVie’s Vital and Virage fixation systems and Brainlab spine and trauma navigation technologies, which help surgeons plan and execute spinal procedures, accurately place pedicle screws, and minimize radiation exposure. In addition, ZimVie will co-market the Brainlab spine and trauma navigation technologies alongside its existing spine implant solutions globally. “We are excited to partner with Brainlab to bring into the operating room differentiated technology aiming at enhancing workflow and accuracy for surgeons and staff,” said Vafa Jamali, President and Chief Executive Officer of ZimVie. “We have been focused on expanding our portfolio with enabling technology to drive greater adoption across our spine portfolio. Our common interest in delivering clinical and economic value to our customers and patients aligns perfectly with ZimVie’s strategic initiatives.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ZIMV:
- ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing
- ZimVie announces FDA approval for Mobi-C implant
- ZimVie price target raised to $11 from $7 at Barclays
- ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance
- ZimVie considering alternatives after receiving interest, Dealreporter says